Sodium Methyldithiocarbamate Inhibits MAP Kinase Activation through Toll-like Receptor 4, Alters Cytokine Production by Mouse Peritoneal Macrophages, and Suppresses Innate Immunity
- 2 June 2005
- journal article
- Published by Oxford University Press (OUP) in Toxicological Sciences
- Vol. 87 (1), 75-85
- https://doi.org/10.1093/toxsci/kfi215
Abstract
Sodium methyldithiocarbamate (SMD; trade name, Metam Sodium) is an abundantly used soil fumigant that can cause adverse health effects in humans, including some immunological manifestations. The mechanisms by which SMD acts, and its targets within the immune system are not fully understood. Initial experiments demonstrated that SMD administered by oral gavage substantially decreased IL-12 production and increased IL-10 production induced by lipopolysaccharide in mice. The present study was conducted to further characterize these effects and to evaluate our working hypothesis that the mechanism for these effects involves alteration in signaling through toll-like receptor 4 and that this would suppress innate immunity to infection. SMD decreased the activation of MAP kinases and AP-1 but not NF-κB in peritoneal macrophages. The expression of mRNA for IL-1α, IL-1β, IL-18, IFN-γ, IL-12 p35, IL-12 p40, and macrophage migration inhibitory factor (MIF) was inhibited by SMD, whereas mRNA for IL-10 was increased. SMD increased the IL-10 concentration in the peritoneal cavity and serum and decreased the concentration of IL-12 p40 in the serum, peritoneal cavity, and intracellularly in peritoneal cells (which are >80% macrophages). Similar effects on LPS-induced cytokine production were observed following dermal administration of SMD. The major breakdown product of SMD, methylisothiocyanate (MITC), caused similar effects on cytokine production at dosages as low as 17 mg/kg, a dosage relevant to human exposure levels associated with agricultural use of SMD. Treatment of mice with SMD decreased survival following challenge with non-pathogenic Escherichia coli within 24–48 h, demonstrating suppression of innate immunity.Keywords
This publication has 59 references indexed in Scilit:
- Activation of cannabinoid CB2 receptor negatively regulates IL‐12p40 production in murine macrophages: role of IL‐10 and ERK1/2 kinase signalingBritish Journal of Pharmacology, 2005
- Protection from spontaneous hepatocellular damage by N-benzyl-d-glucamine dithiocarbamate in Long–Evans Cinnamon rats, an animal model of Wilson's diseaseToxicology and Applied Pharmacology, 2005
- Modeling and Predicting Immunological Effects of Chemical Stressors: Characterization of a Quantitative Biomarker for Immunological Changes Caused by Atrazine and EthanolToxicological Sciences, 2003
- Macrophage migration inhibitory factor (MIF) modulates innate immune responses induced by endotoxin and Gram-negative bacteriaInnate Immunity, 2001
- Novel biphasic effect of pyrrolidine dithiocarbamate on neuronal cell viability is mediated by the differential regulation of intracellular zinc and copper ion levels, NF-?b, and MAP kinasesJournal of Neuroscience Research, 2000
- ROLE OF DECOMPOSITION PRODUCTS IN SODIUM METHYLDITHIOCARBAMATE-INDUCED IMMUNOTOXICITYJournal of Toxicology and Environmental Health, 1996
- Interleukin-12 and its role in the generation of TH1 cellsImmunology Today, 1993
- Disparate effects of representative dithiocarbamates on selected immunological parameters in vivo and cell survival in vitro in female B6C3F1 miceJournal of Toxicology and Environmental Health, 1992
- Immunotoxicological characteristics of sodium methyldithiocarbamateFundamental and Applied Toxicology, 1992
- Antioxidant capacity of diethyldithiocarbamate in a metal independent lipid peroxidative processFree Radical Biology & Medicine, 1989